![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 1.
Rothschedl, E. and Grössmann, N. : Atezolizumab (Tecentriq®) as monotherapy for the first-line treatment of advanced NSCLC. Fact Sheet Nr. 190.
Rothschedl, E. and Grössmann, N. : Atezolizumab (Tecentriq®) as monotherapy for the first-line treatment of advanced NSCLC. Fact Sheet Nr. 190.